Last Updated on August 7, 2021 by The Health Master
Covaxin has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities, Bharat Biotech said in a statement.
The approval received is from the National Institute of Pharmacy and Nutrition Hungary certifying the GMP for the manufacturing of Covaxin.
The certificate of GMP is now listed on the EudraGMDP database, which is the database of the European Community of manufacturing authorisations and certificates of the good manufacturing practice.
Bharat Biotech intends to submit documentation for Emergency Use Authorisation (EUA) in several additional countries worldwide, it added.
Zydus Cadila gets final nod from USFDA for Fulvestrant injection
USFDA inspection ends with ‘Zero’ observations: Alkem
Granules Pharma clears USFDA audit
Zydus Cadila gets USFDA nod for Ibrutinib tablets
Lupin gets USFDA nod for generic Antifungal drug
Unichem gets tentative USFDA nod for drug to treat Diabetes
7 Tips Every Men Should Follow In Healthy Skincare Regime
Only 0.20% of drug samples declared Adulterated in FY 2020-21
Govt to amend New Drugs and Clinical Trials Rules 2019
CDSCO approves 12 laboratories for BA/BE studies
FAQs on Medical Devices Rules, 2017
FAQs on New Drug, Banned drugs etc.
For informative videos by The Health Master, click on the below YouTube icon: